Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD10 expression in diffuse large B-cell lymphomas does not influence survival.
Fabiani B, Delmer A, Lepage E, Guettier C, Petrella T, Brière J, Penny AM, Copin MC, Diebold J, Reyes F, Gaulard P, Molina TJ; Groupe d'Etudes des Lymphomes de l'Adulte. Fabiani B, et al. Among authors: lepage e. Virchows Arch. 2004 Dec;445(6):545-51. doi: 10.1007/s00428-004-1129-7. Epub 2004 Oct 27. Virchows Arch. 2004. PMID: 15517363 Review.
Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
Besson C, Canioni D, Lepage E, Pol S, Morel P, Lederlin P, Van Hoof A, Tilly H, Gaulard P, Coiffier B, Gisselbrecht C, Brousse N, Reyes F, Hermine O; Groupe d'Etude des Lymphomes de l'Adulte Programs. Besson C, et al. Among authors: lepage e. J Clin Oncol. 2006 Feb 20;24(6):953-60. doi: 10.1200/JCO.2005.01.5016. Epub 2006 Jan 17. J Clin Oncol. 2006. PMID: 16418500
Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.
Gisselbrecht C, Lepage E, Molina T, Quesnel B, Fillet G, Lederlin P, Coiffier B, Tilly H, Gabarre J, Guilmin F, Hermine O, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte. Gisselbrecht C, et al. Among authors: lepage e. J Clin Oncol. 2002 May 15;20(10):2472-9. doi: 10.1200/JCO.2002.02.125. J Clin Oncol. 2002. PMID: 12011124 Free article. Clinical Trial.
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
Reyes F, Lepage E, Ganem G, Molina TJ, Brice P, Coiffier B, Morel P, Ferme C, Bosly A, Lederlin P, Laurent G, Tilly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA). Reyes F, et al. Among authors: lepage e. N Engl J Med. 2005 Mar 24;352(12):1197-205. doi: 10.1056/NEJMoa042040. N Engl J Med. 2005. PMID: 15788496 Free article. Clinical Trial.
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.
Tilly H, Lepage E, Coiffier B, Blanc M, Herbrecht R, Bosly A, Attal M, Fillet G, Guettier C, Molina TJ, Gisselbrecht C, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte. Tilly H, et al. Among authors: lepage e. Blood. 2003 Dec 15;102(13):4284-9. doi: 10.1182/blood-2003-02-0542. Epub 2003 Aug 14. Blood. 2003. PMID: 12920037 Free article. Clinical Trial.
Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the Groupe d'Etude des Lymphomes Folliculaires.
Canioni D, Brice P, Lepage E, Chababi M, Meignin V, Salles B, Xerri L, Péaud PY, Rousselot P, Peuchmaur M, Solal-Céligny P, Brousse N; Groupe d'Etude des Lymphomes Folliculaires. Canioni D, et al. Among authors: lepage e. Br J Haematol. 2004 Aug;126(3):364-71. doi: 10.1111/j.1365-2141.2004.05046.x. Br J Haematol. 2004. PMID: 15257708 Free article.
203 results